Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Technological advancements in immunofluorescence assays
3.2.1.3 Growing research and development activities
3.2.1.4 Rising adoption of point-of-care testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.6.1 Core technologies
3.6.2 Adjacent technologies
3.7 Pricing analysis, 2023
3.7.1 By region
3.7.2 By key player
3.8 Future market trends
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Antibodies
5.3 Kits and reagents
5.4 Instruments
5.5 Consumables and accessories
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Indirect immunofluorescence
6.3 Direct immunofluorescence
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cancer
7.3 Infectious diseases
7.4 Cardiovascular diseases
7.5 Autoimmune diseases
7.6 Other diseases
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Academic & research institutes
8.3 Pharmaceutical & biotechnology companies
8.4 Contract research organizations
8.5 Hospitals & diagnostic centers
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Agilent Technologies, Inc.
10.2 Bio-Rad Laboratories, Inc.
10.3 Cell Signaling Technology, Inc.
10.4 Danaher Corporation
10.5 EpigenTek Group Inc.
10.6 MaxVision Biosciences Inc.
10.7 Medipan GmbH
10.8 Merck & Co., Inc.
10.9 J. Mitra & Co. Pvt. Ltd.
10.10 Nikon Corporation
10.11 Olympus Corporation
10.12 PerkinElmer, Inc.
10.13 Sino Biological, Inc.
10.14 Thermo Fisher Scientific Inc.
10.15 Werfen
